Patients with advanced lung cancer: is there scope to discontinue inappropriate medication?

ISSN： 2210-7703

Source： International Journal of Clinical Pharmacy, Vol.35, Iss.2, 2013-04, pp. : 181-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevalence of Potentially Inappropriate Medication Use in Elderly Hospitalised Patients

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 41, Iss. 2, 2011-06 ,pp. : 122-125

John Wiley & Sons Inc

Access to resources Recommend Favorite

Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first-line treatment of patients with advanced breast cancer: Phase 3 randomized trial

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3412-3421

Blackwell Publishing

Access to resources Recommend Favorite

Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer

By Goto Yasushi

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1548-1556

Springer Publishing Company

Access to resources Recommend Favorite

Optimal Pharmacotherapeutic Strategies for Elderly Patients with Advanced Non-Small Cell Lung Cancer

By Quoix Elisabeth

Drugs & Aging, Vol. 28, Iss. 11, 2011-11 ,pp. : 885-894

Adis International

Access to resources Recommend Favorite

Vinorelbine: A Review of its Use in Elderly Patients with Advanced Non-Small Cell Lung Cancer

By Curran M.P. Plosker G.L.

Drugs & Aging, Vol. 19, Iss. 9, 2002-01 ,pp. : 695-721

Adis International

Access to resources Recommend Favorite